Interdisciplinary Models for Research and Clinical Endeavors in Genomic Medicine: A Scientific Statement From the American Heart Association.

The completion of the Human Genome Project has unleashed a wealth of human genomics information, but it remains unclear how best to implement this information for the benefit of patients. The standard approach of biomedical research, with researchers pursuing advances in knowledge in the laboratory and, separately, clinicians translating research findings into the clinic as much as decades later, will need to give way to new interdisciplinary models for research in genomic medicine. These models should include scientists and clinicians actively working as teams to study patients and populations recruited in clinical settings and communities to make genomics discoveries-through the combined efforts of data scientists, clinical researchers, epidemiologists, and basic scientists-and to rapidly apply these discoveries in the clinic for the prediction, prevention, diagnosis, prognosis, and treatment of cardiovascular diseases and stroke. The highly publicized US Precision Medicine Initiative, also known as All of Us, is a large-scale program funded by the US National Institutes of Health that will energize these efforts, but several ongoing studies such as the UK Biobank Initiative; the Million Veteran Program; the Electronic Medical Records and Genomics Network; the Kaiser Permanente Research Program on Genes, Environment and Health; and the DiscovEHR collaboration are already providing exemplary models of this kind of interdisciplinary work. In this statement, we outline the opportunities and challenges in broadly implementing new interdisciplinary models in academic medical centers and community settings and bringing the promise of genomics to fruition.

[1]  Steven R Houser,et al.  Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling and Precision Medicine: A Scientific Statement From the American Heart Association. , 2018, Circulation. Genomic and precision medicine.

[2]  Jeffrey L. Anderson,et al.  Effect of Genotype-Guided Warfarin Dosing on Clinical Events and Anticoagulation Control Among Patients Undergoing Hip or Knee Arthroplasty: The GIFT Randomized Clinical Trial , 2017, JAMA.

[3]  Vishnu Mohan,et al.  Use of Simulation Based on an Electronic Health Records Environment to Evaluate the Structure and Accuracy of Notes Generated by Medical Scribes: Proof-of-Concept Study , 2017, JMIR medical informatics.

[4]  Kaberi Dasgupta,et al.  Validity of Health Administrative Database Definitions for Hypertension: A Systematic Review. , 2017, The Canadian journal of cardiology.

[5]  M. Fornage,et al.  The Expressed Genome in Cardiovascular Diseases and Stroke: Refinement, Diagnosis, and Prediction A Scientific Statement From the American Heart Association , 2017, Circulation. Cardiovascular genetics.

[6]  S. Gabriel,et al.  Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease , 2017, The New England journal of medicine.

[7]  Tanya M. Teslovich,et al.  Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease , 2017, The New England journal of medicine.

[8]  D. Rader,et al.  Lack of MTTP Activity in Pluripotent Stem Cell-Derived Hepatocytes and Cardiomyocytes Abolishes apoB Secretion and Increases Cell Stress. , 2017, Cell reports.

[9]  Davis J. McCarthy,et al.  Common genetic variation drives molecular heterogeneity in human iPSCs , 2017, Nature.

[10]  D. Rader,et al.  A Drug Screen using Human iPSC-Derived Hepatocyte-like Cells Reveals Cardiac Glycosides as a Potential Treatment for Hypercholesterolemia. , 2017, Cell stem cell.

[11]  Gaurav Pandey,et al.  Analysis of Transcriptional Variability in a Large Human iPSC Library Reveals Genetic and Non-genetic Determinants of Heterogeneity. , 2017, Cell stem cell.

[12]  Fabian Grubert,et al.  Patient-Specific iPSC-Derived Endothelial Cells Uncover Pathways that Protect against Pulmonary Hypertension in BMPR2 Mutation Carriers. , 2017, Cell stem cell.

[13]  Christopher D. Brown,et al.  Large, Diverse Population Cohorts of hiPSCs and Derived Hepatocyte-like Cells Reveal Functional Genetic Variation at Blood Lipid-Associated Loci. , 2017, Cell stem cell.

[14]  Bing Ren,et al.  Large-Scale Profiling Reveals the Influence of Genetic Variation on Gene Expression in Human Induced Pluripotent Stem Cells. , 2017, Cell stem cell.

[15]  J. Danesh,et al.  ANGPTL3 Deficiency and Protection Against Coronary Artery Disease. , 2017, Journal of the American College of Cardiology.

[16]  O. Fiehn,et al.  Potential Impact and Study Considerations of Metabolomics in Cardiovascular Health and Disease: A Scientific Statement From the American Heart Association. , 2017, Circulation. Cardiovascular genetics.

[17]  Praveen Shukla,et al.  High-throughput screening of tyrosine kinase inhibitor cardiotoxicity with human induced pluripotent stem cells , 2017, Science Translational Medicine.

[18]  Johan Sundström,et al.  Epigenetic Patterns in Blood Associated With Lipid Traits Predict Incident Coronary Heart Disease Events and Are Enriched for Results From Genome-Wide Association Studies , 2017, Circulation. Cardiovascular genetics.

[19]  Marylyn D. Ritchie,et al.  Distribution and clinical impact of functional variants in 50,726 whole-exome sequences from the DiscovEHR study , 2016, Science.

[20]  N. Cook,et al.  The Pooled Cohort Equations 3 Years On: Building a Stronger Foundation. , 2016, Circulation.

[21]  E. Boerwinkle,et al.  Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease. , 2016, The New England journal of medicine.

[22]  Inês Barroso,et al.  Prospective functional classification of all possible missense variants in PPARG , 2016, Nature Genetics.

[23]  Joseph Loscalzo,et al.  Precision medicine in cardiology , 2016, Nature Reviews Cardiology.

[24]  M. Perez,et al.  Enhancing Literacy in Cardiovascular Genetics: A Scientific Statement From the American Heart Association , 2016, Circulation. Cardiovascular genetics.

[25]  Michael P Snyder,et al.  Transcriptome Profiling of Patient-Specific Human iPSC-Cardiomyocytes Predicts Individual Drug Safety and Efficacy Responses In Vitro. , 2016, Cell stem cell.

[26]  D. Roden,et al.  Phenome-Wide Association Studies as a Tool to Advance Precision Medicine. , 2016, Annual review of genomics and human genetics.

[27]  Tom Michoel,et al.  Cardiometabolic risk loci share downstream cis- and trans-gene regulation across tissues and diseases , 2016, Science.

[28]  Stephanie Devaney,et al.  A Survey of U.S Adults’ Opinions about Conduct of a Nationwide Precision Medicine Initiative® Cohort Study of Genes and Environment , 2016, PloS one.

[29]  Samantha A. Adams,et al.  Precision medicine: opportunities, possibilities, and challenges for patients and providers , 2016, J. Am. Medical Informatics Assoc..

[30]  Brian J. Bennett,et al.  Nutrigenomics, the Microbiome, and Gene-Environment Interactions: New Directions in Cardiovascular Disease Research, Prevention, and Treatment A Scientific Statement From the American Heart Association , 2016, Circulation. Cardiovascular genetics.

[31]  J. Rumsfeld,et al.  Big data analytics to improve cardiovascular care: promise and challenges , 2016, Nature Reviews Cardiology.

[32]  D. Gudbjartsson,et al.  Variant ASGR1 Associated with a Reduced Risk of Coronary Artery Disease. , 2016, The New England journal of medicine.

[33]  Alexander E. Lopez,et al.  Inactivating Variants in ANGPTL4 and Risk of Coronary Artery Disease. , 2016, The New England journal of medicine.

[34]  W. Riley,et al.  Precision Public Health for the Era of Precision Medicine. , 2016, American journal of preventive medicine.

[35]  Mary Brophy,et al.  Million Veteran Program: A mega-biobank to study genetic influences on health and disease. , 2016, Journal of clinical epidemiology.

[36]  S. Kardia,et al.  Expert and Advocacy Group Consensus Findings on the Horizon of Public Health Genetic Testing , 2016, Healthcare.

[37]  M. Hurles,et al.  Attitudes of nearly 7000 health professionals, genomic researchers and publics toward the return of incidental results from sequencing research , 2015, European Journal of Human Genetics.

[38]  Exome sequencing identifies rare LDLR and APOA 5 alleles conferring risk for myocardial infarction , 2016 .

[39]  Coding Variation in ANGPTL 4 , LPL , and SVEP 1 and the Risk of Coronary Disease Myocardial Infarction Genetics and CARDIoGRAM Exome Consortia , 2016 .

[40]  Rajiv,et al.  Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease. , 2016, The New England journal of medicine.

[41]  A. Trepanier,et al.  Comparison of Informed Consent Preferences for Multiplex Genetic Carrier Screening among a Diverse Population , 2016, Journal of Genetic Counseling.

[42]  Gabor T. Marth,et al.  A global reference for human genetic variation , 2015, Nature.

[43]  Yu-Fang Jin,et al.  Transformative Impact of Proteomics on Cardiovascular Health and Disease: A Scientific Statement From the American Heart Association , 2015, Circulation.

[44]  D. Sargent,et al.  Genotype-based clinical trials in cardiovascular disease , 2015, Nature Reviews Cardiology.

[45]  Donald M Bers,et al.  Epigenetic Regulation of Phosphodiesterases 2A and 3A Underlies Compromised β-Adrenergic Signaling in an iPSC Model of Dilated Cardiomyopathy. , 2015, Cell stem cell.

[46]  Teresa A. Webster,et al.  Genotyping Informatics and Quality Control for 100,000 Subjects in the Genetic Epidemiology Research on Adult Health and Aging (GERA) Cohort , 2015, Genetics.

[47]  David R. Williams,et al.  Calling for a bold new vision of health disparities intervention research. , 2015, American journal of public health.

[48]  W. Chung,et al.  Development of a tiered and binned genetic counseling model for informed consent in the era of multiplex testing for cancer susceptibility , 2014, Genetics in Medicine.

[49]  Jun S. Liu,et al.  The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans , 2015, Science.

[50]  C. Newgard,et al.  Integrated metabolomics and genomics: systems approaches to biomarkers and mechanisms of cardiovascular disease. , 2015, Circulation. Cardiovascular genetics.

[51]  Thomas May On the Justifiability of ACMG Recommendations for Reporting of Incidental Findings in Clinical Exome and Genome Sequencing , 2015, Journal of Law, Medicine & Ethics.

[52]  P. Elliott,et al.  UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age , 2015, PLoS medicine.

[53]  A. Barabasi,et al.  Uncovering disease-disease relationships through the incomplete interactome , 2015, Science.

[54]  John W McEvoy,et al.  An analysis of calibration and discrimination among multiple cardiovascular risk scores in a modern multiethnic cohort. , 2015, Annals of internal medicine.

[55]  Terri Voepel-Lewis,et al.  Digital multimedia: a new approach for informed consent? , 2015, JAMA.

[56]  M. Fornage,et al.  Basic concepts and potential applications of genetics and genomics for cardiovascular and stroke clinicians: a scientific statement from the American Heart Association. , 2015, Circulation. Cardiovascular genetics.

[57]  Eric S. Lander,et al.  Systematic Cell-Based Phenotyping of Missense Alleles Empowers Rare Variant Association Studies: A Case for LDLR and Myocardial Infarction , 2015, PLoS genetics.

[58]  Andrew D. Johnson,et al.  Multiple rare alleles at LDLR and APOA5 confer risk for early-onset myocardial infarction , 2014, Nature.

[59]  John Spertus,et al.  Inactivating mutations in NPC1L1 and protection from coronary heart disease. , 2014, The New England journal of medicine.

[60]  Pierre Fontanillas,et al.  Rare variants in PPARG with decreased activity in adipocyte differentiation are associated with increased risk of type 2 diabetes , 2014, Proceedings of the National Academy of Sciences.

[61]  Michelle Dunn,et al.  The National Institutes of Health's Big Data to Knowledge (BD2K) initiative: capitalizing on biomedical big data , 2014, J. Am. Medical Informatics Assoc..

[62]  B. Nordestgaard,et al.  Loss-of-function mutations in APOC3 and risk of ischemic vascular disease. , 2014, The New England journal of medicine.

[63]  He Zhang,et al.  Loss-of-function mutations in APOC3, triglycerides, and coronary disease. , 2014, The New England journal of medicine.

[64]  Susan E. Sheridan,et al.  Patient-powered research networks aim to improve patient care and health research. , 2014, Health affairs.

[65]  Richard Platt,et al.  Four health data networks illustrate the potential for a shared national multipurpose big-data network. , 2014, Health affairs.

[66]  Jennifer G. Robinson,et al.  2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2014, Circulation.

[67]  He Zhang,et al.  Systematic evaluation of coding variation identifies a candidate causal variant in TM6SF2 influencing total cholesterol and myocardial infarction risk , 2014, Nature Genetics.

[68]  Anne Tybjærg-Hansen,et al.  Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease , 2014, Nature Genetics.

[69]  Jennifer G. Robinson,et al.  Association of low-frequency and rare coding-sequence variants with blood lipids and coronary heart disease in 56,000 whites and blacks. , 2014, American journal of human genetics.

[70]  N. Eriksson,et al.  A randomized trial of genotype-guided dosing of warfarin. , 2013, The New England journal of medicine.

[71]  Melissa A. Basford,et al.  Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data , 2013, Nature Biotechnology.

[72]  M. Drazner,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.

[73]  Tanya M. Teslovich,et al.  Discovery and refinement of loci associated with lipid levels , 2013, Nature Genetics.

[74]  Marc S. Williams,et al.  ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing , 2013, Genetics in Medicine.

[75]  Melissa A. Basford,et al.  The Electronic Medical Records and Genomics (eMERGE) Network: past, present, and future , 2013, Genetics in Medicine.

[76]  Chad A. Cowan,et al.  Enhanced efficiency of human pluripotent stem cell genome editing through replacing TALENs with CRISPRs. , 2013, Cell stem cell.

[77]  G. Omenn,et al.  Evolution of Translational Omics: Lessons Learned and the Path Forward , 2013 .

[78]  Melissa A. Basford,et al.  Genome- and Phenome-Wide Analyses of Cardiac Conduction Identifies Markers of Arrhythmia Risk , 2013, Circulation.

[79]  P. Douglas,et al.  A Blood-Based Gene Expression Test for Obstructive Coronary Artery Disease Tested in Symptomatic Nondiabetic Patients Referred for Myocardial Perfusion Imaging The COMPASS Study , 2013, Circulation. Cardiovascular genetics.

[80]  Kevin Kim,et al.  A TALEN genome-editing system for generating human stem cell-based disease models. , 2013, Cell stem cell.

[81]  Gordon Keller,et al.  Induced pluripotent stem cells used to reveal drug actions in a long QT syndrome family with complex genetics , 2013, The Journal of general physiology.

[82]  N. Norton,et al.  Return of Genetic Results in the Familial Dilated Cardiomyopathy Research Project , 2013, Journal of Genetic Counseling.

[83]  P. Ridker,et al.  Kinesin-Like Protein 6 (KIF6) Polymorphism and the Efficacy of Rosuvastatin in Primary Prevention , 2011, Circulation. Cardiovascular genetics.

[84]  R. Collins,et al.  No impact of KIF6 genotype on vascular risk and statin response among 18,348 randomized patients in the heart protection study. , 2011, Journal of the American College of Cardiology.

[85]  Thomas J. Wang,et al.  Assessing the Role of Circulating, Genetic, and Imaging Biomarkers in Cardiovascular Risk Prediction , 2011, Circulation.

[86]  Szilard Voros,et al.  Development of a blood-based gene expression algorithm for assessment of obstructive coronary artery disease in non-diabetic patients , 2011, BMC Medical Genomics.

[87]  Zahi A Fayad,et al.  2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2010, Circulation.

[88]  Zahi A Fayad,et al.  2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2010, Journal of the American College of Cardiology.

[89]  Jonathan C. Cohen,et al.  Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia. , 2010, The New England journal of medicine.

[90]  Alexander F. Wilson,et al.  Lack of association between the Trp719Arg polymorphism in kinesin-like protein-6 and coronary artery disease in 19 case-control studies. , 2010, Journal of the American College of Cardiology.

[91]  Szilard Voros,et al.  Multicenter Validation of the Diagnostic Accuracy of a Blood-Based Gene Expression Test for Assessing Obstructive Coronary Artery Disease in Nondiabetic Patients , 2010, Annals of Internal Medicine.

[92]  Olle Melander,et al.  From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus , 2010, Nature.

[93]  J. Catanese,et al.  KIF6 Trp719Arg polymorphism and the effect of statin therapy in elderly patients: results from the PROSPER study , 2010, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[94]  Tanya M. Teslovich,et al.  Biological, Clinical, and Population Relevance of 95 Loci for Blood Lipids , 2010, Nature.

[95]  B. Akolkar,et al.  Biobanking, consent, and commercialization in international genetics research: the Type 1 Diabetes Genetics Consortium , 2010, Clinical trials.

[96]  Teri A Manolio,et al.  Genomewide association studies and assessment of the risk of disease. , 2010, The New England journal of medicine.

[97]  James Yee,et al.  Gene-expression profiling for rejection surveillance after cardiac transplantation. , 2010, The New England journal of medicine.

[98]  Heather Skirton,et al.  Genetic education and the challenge of genomic medicine: development of core competences to support preparation of health professionals in Europe , 2010, European Journal of Human Genetics.

[99]  M. Sabatine,et al.  Effect of pravastatin therapy on coronary events in carriers of the KIF6 719Arg allele from the cholesterol and recurrent events trial. , 2010, The American journal of cardiology.

[100]  Marylyn D. Ritchie,et al.  PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene–disease associations , 2010, Bioinform..

[101]  Jeffrey L. Anderson,et al.  ACCF / AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults , 2010 .

[102]  A. Barabasi,et al.  Network medicine : a network-based approach to human disease , 2010 .

[103]  J. Ioannidis,et al.  Assessment of claims of improved prediction beyond the Framingham risk score. , 2009, JAMA.

[104]  I. Tikhonova,et al.  Genetic diagnosis by whole exome capture and massively parallel DNA sequencing , 2009, Proceedings of the National Academy of Sciences.

[105]  Emily H Turner,et al.  Targeted Capture and Massively Parallel Sequencing of Twelve Human Exomes , 2009, Nature.

[106]  R. Collins,et al.  Common variants at 30 loci contribute to polygenic dyslipidemia , 2009, Nature Genetics.

[107]  Gail Geller,et al.  Public Expectations for Return of Results from Large-Cohort Genetic Research , 2008, The American journal of bioethics : AJOB.

[108]  Geoffrey S Ginsburg,et al.  Correlation of Peripheral-Blood Gene Expression With the Extent of Coronary Artery Stenosis , 2008, Circulation. Cardiovascular genetics.

[109]  A. Fiester Justifying a Presumption of Restraint in Animal Biotechnology Research , 2008, The American journal of bioethics : AJOB.

[110]  R. Collins,et al.  SLCO1B1 variants and statin-induced myopathy--a genomewide study. , 2008, The New England journal of medicine.

[111]  R. Collins,et al.  Newly identified loci that influence lipid concentrations and risk of coronary artery disease , 2008, Nature Genetics.

[112]  M. Pencina,et al.  Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond , 2008, Statistics in medicine.

[113]  P. Ridker,et al.  A kinesin family member 6 variant is associated with coronary heart disease in the Women's Health Study. , 2008, Journal of the American College of Cardiology.

[114]  Marc A Pfeffer,et al.  Association of the Trp719Arg polymorphism in kinesin-like protein 6 with myocardial infarction and coronary heart disease in 2 prospective trials: the CARE and WOSCOPS trials. , 2008, Journal of the American College of Cardiology.

[115]  M. Sabatine,et al.  Polymorphism in KIF6 gene and benefit from statins after acute coronary syndromes: results from the PROVE IT-TIMI 22 study. , 2008, Journal of the American College of Cardiology.

[116]  Dolores Corella,et al.  Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans , 2008, Nature Genetics.

[117]  T. Pawson,et al.  Network medicine , 2008, FEBS letters.

[118]  H. Greely The uneasy ethical and legal underpinnings of large-scale genomic biobanks. , 2007, Annual review of genomics and human genetics.

[119]  C. Gieger,et al.  Genomewide association analysis of coronary artery disease. , 2007, The New England journal of medicine.

[120]  B. Knoppers,et al.  Trends in ethical and legal frameworks for the use of human biobanks , 2007, European Respiratory Journal.

[121]  A. Gylfason,et al.  A Common Variant on Chromosome 9p21 Affects the Risk of Myocardial Infarction , 2007, Science.

[122]  Marcia M. Nizzari,et al.  Genome-Wide Association Analysis Identifies Loci for Type 2 Diabetes and Triglyceride Levels , 2007, Science.

[123]  Jonathan C. Cohen,et al.  A Common Allele on Chromosome 9 Associated with Coronary Heart Disease , 2007, Science.

[124]  N. Cook Use and Misuse of the Receiver Operating Characteristic Curve in Risk Prediction , 2007, Circulation.

[125]  Christian Gieger,et al.  A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization , 2006, Nature Genetics.

[126]  T. Klingler,et al.  Noninvasive Discrimination of Rejection in Cardiac Allograft Recipients Using Gene Expression Profiling , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[127]  John F. Hurdle,et al.  Measuring diagnoses: ICD code accuracy. , 2005, Health services research.

[128]  J. Ott,et al.  Complement Factor H Polymorphism in Age-Related Macular Degeneration , 2005, Science.

[129]  M. Olivier A haplotype map of the human genome. , 2003, Nature.

[130]  M. Olivier A haplotype map of the human genome , 2003, Nature.

[131]  D. Levy,et al.  Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.

[132]  D. Hosmer,et al.  A review of goodness of fit statistics for use in the development of logistic regression models. , 1982, American journal of epidemiology.